Head & Neck Cancer Drugs Market by Drug Class (Chemotherapy, Immunotherapy, and Targeted Therapy) and Sales Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Stores): Global Opportunity Analysis and Industry Forecast, 2018 - 2025 Update Available On-Demand

Abstract
Apex Market Research has published a new report titled ”Global Head and Neck Cancer Drugs Market share, forecast data, In-Depth Analysis, and Forecast, 2020-2027”. According to the report, The global head & neck cancer drugs market was valued at $1,295 million in 2017, and is projected to reach $2,281 million by 2025, registering a CAGR of 7.3% The report offers in-depth insights, revenue details, and other vital information regarding the global Head and Neck Cancer Drugs market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.

Attractive Opportunities in the Head and Neck Cancer Drugs market

The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Global Head and Neck Cancer Drugs market report offers in-depth insights, revenue details, and other vital information regarding the global Head and Neck Cancer Drugs market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period.
It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest shareholder of Head and Neck Cancer Drugs market. The major players operating into Head and Neck Cancer Drugs Market include: straZeneca PLC
Bristol-Myers Squibb Company
Eli Lilly and Company (ARMO Biosciences)
Fortress Biotech Inc. (Checkpoint Therapeutics
Inc.)
F. Hoffmann-La Roche Ltd. (GenentechInc.)
Immutep Limited
Merck & Co.Inc.
Merck KGaA (EMD Serono Inc.)
Novartis AG
Pfizer Inc.
Scope Of the Report
Report Parameters Details of Parameter
Market Size 2020-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD
Covered Segments Drug Class, Sales Channel
Region Covered North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)
This research report categorizes the Head and Neck Cancer Drugs market to forecast revenues and analyze trends in each of the following submarkets:

By Drug Class

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy

By Sales Channel

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Stores
By geography, this market has been segregated into five regions with revenue and growth rate of Head and Neck Cancer Drugs from 2020 to 2027,
There are 13 chapters to put on view for Head and Neck Cancer Drugs Market:
Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Head and Neck Cancer Drugs Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Head and Neck Cancer Drugs Market Overview 1.1.1 Head and Neck Cancer Drugs Product Scope 1.1.2 Market Status and Outlook 1.2 Global Head and Neck Cancer Drugs Market Size and Analysis by Regions (2015-2019) 1.2.1 North America Head and Neck Cancer Drugs Market Status and Outlook 1.2.2 EU Head and Neck Cancer Drugs Market Status and Outlook 1.2.3 Japan Head and Neck Cancer Drugs Market Status and Outlook 1.2.4 China Head and Neck Cancer Drugs Market Status and Outlook 1.2.5 India Head and Neck Cancer Drugs Market Status and Outlook 1.2.6 Southeast Asia Head and Neck Cancer Drugs Market Status and Outlook 1.3 Global Head and Neck Cancer Drugs Market Segment Drug Class
1.3.1 Introduction
1.3.1.1 Market Estimates And Forecast 2015-2027
1.3.2 Chemotherapy
1.3.2.1 Market Estimates And Forecast By Country, 2015-2027
1.3.3 Immunotherapy
1.3.3.1 Market Estimates And Forecast By Country, 2015-2027
1.3.4 Targeted Therapy
1.3.4.1 Market Estimates And Forecast By Country, 2015-2027
1.4 Global Head and Neck Cancer Drugs Market Segment Sales Channel
1.4.1 Introduction
1.4.1.1 Market Estimates And Forecast 2015-2027
1.4.2 Hospital Pharmacies
1.4.2.1 Market Estimates And Forecast By Country, 2015-2027
1.4.3 Drug Stores & Retail Pharmacies
1.4.3.1 Market Estimates And Forecast By Country, 2015-2027
1.4.4 Online Stores
1.4.4.1 Market Estimates And Forecast By Country, 2015-2027
Chapter 2 Global Head and Neck Cancer Drugs Competition Analysis by Players 2.1 Global Head and Neck Cancer Drugs Market Size (Million USD) by Players (2015-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 straZeneca PLC 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 straZeneca PLC, Head and Neck Cancer Drugs Revenue (Million USD) (2015-2019) 3.1.5 Recent Developments 3.2 Bristol-Myers Squibb Company 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Bristol-Myers Squibb Company, Head and Neck Cancer Drugs Revenue (Million USD) (2015-2019) 3.2.5 Recent Developments 3.3 Eli Lilly and Company (ARMO Biosciences) 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Eli Lilly and Company (ARMO Biosciences), Head and Neck Cancer Drugs Revenue (Million USD) (2015-2019) 3.3.5 Recent Developments 3.4 Fortress Biotech Inc. (Checkpoint Therapeutics 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Fortress Biotech Inc. (Checkpoint Therapeutics, Head and Neck Cancer Drugs Revenue (Million USD) (2015-2019) 3.4.5 Recent Developments 3.5 Inc.) 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Inc.), Head and Neck Cancer Drugs Revenue (Million USD)(2015-2019) 3.5.5 Recent Developments 3.6 F. Hoffmann-La Roche Ltd. (GenentechInc.) 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 F. Hoffmann-La Roche Ltd. (GenentechInc.), Head and Neck Cancer Drugs Revenue (Million USD)(2015-2019) 3.6.5 Recent Developments 3.7 Immutep Limited 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Immutep Limited, Head and Neck Cancer Drugs Revenue (Million USD)(2015-2019) 3.7.5 Recent Developments 3.8 Merck & Co.Inc. 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Merck & Co.Inc., Head and Neck Cancer Drugs Revenue (Million USD) (2015-2019) 3.8.5 Recent Developments 3.9 Merck KGaA (EMD Serono Inc.) 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Merck KGaA (EMD Serono Inc.), Head and Neck Cancer Drugs Revenue (Million USD) (2015-2019) 3.9.5 Recent Developments 3.10 Novartis AG 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 Novartis AG, Head and Neck Cancer Drugs Revenue (Million USD) (2015-2019) 3.10.5 Recent Developments Chapter 4 Global Head and Neck Cancer Drugs Market Size Type (2015-2019) 4.1 Global Head and Neck Cancer Drugs Market Size by Type (2015-2019) Chapter 5 Global Head and Neck Cancer Drugs Market Size Application (2015-2019) 5.1 Global Head and Neck Cancer Drugs Market Size by Application (2015-2019) 5.2 Potential Application of Head and Neck Cancer Drugs in Future 5.3 Top Consumer / End Users of Head and Neck Cancer Drugs Chapter 6 North America Head and Neck Cancer Drugs Development Status and Outlook 6.1 North America Head and Neck Cancer Drugs Market Size (2015-2019) 6.2 North America Head and Neck Cancer Drugs Market Size by Application (2015-2019) Chapter 7 EU Head and Neck Cancer Drugs Development Status and Outlook 7.1 EU Head and Neck Cancer Drugs Market Size (2015-2019) 7.2 EU Head and Neck Cancer Drugs Market Size by Application (2015-2019) Chapter 8 Japan Head and Neck Cancer Drugs Development Status and Outlook 8.1 Japan Head and Neck Cancer Drugs Market Size (2015-2019) 8.2 Japan Head and Neck Cancer Drugs Market Size by Application (2015-2019) Chapter 9 China Head and Neck Cancer Drugs Development Status and Outlook 9.1 China Head and Neck Cancer Drugs Market Size and Forecast (2015-2019) 9.2 China Head and Neck Cancer Drugs Market Size by Application (2015-2019) Chapter 10 India Head and Neck Cancer Drugs Development Status and Outlook 10.1 India Head and Neck Cancer Drugs Market Size and Forecast (2015-2019) 10.2 India Head and Neck Cancer Drugs Market Size by Application (2015-2019) Chapter 11 Southeast Asia Head and Neck Cancer Drugs Development Status and Outlook 11.1 Southeast Asia Head and Neck Cancer Drugs Market Size and Forecast (2015-2019) 11.2 Southeast Asia Head and Neck Cancer Drugs Market Size by Application (2015-2019) Chapter 12 Market Forecast by Regions and Application (2020-2027) 12.1 Global Head and Neck Cancer Drugs Market Size (Million USD) by Regions (2020-2027) 12.1. North America Head and Neck Cancer Drugs Revenue and Growth Rate (2020-2027) 12.1.2 EU Head and Neck Cancer Drugs Revenue and Growth Rate (2020-2027) 12.1.3 China Head and Neck Cancer Drugs Revenue and Growth Rate (2020-2027) 12.1.4 Japan Head and Neck Cancer Drugs Revenue and Growth Rate (2020-2027) 12.1.5 Southeast Asia Head and Neck Cancer Drugs Revenue and Growth Rate (2020-2027) 12.1.6 India Head and Neck Cancer Drugs Revenue and Growth Rate (2020-2027) 12.2 Global Head and Neck Cancer Drugs Market Size by Application (2020-2027) Chapter 13 Head and Neck Cancer Drugs Market Dynamics 13.1 Head and Neck Cancer Drugs Market Opportunities 13.2 Head and Neck Cancer Drugs Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Head and Neck Cancer Drugs Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Head and Neck Cancer Drugs Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
1701

1315

OUR CLIENT